Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel subfamily A member 6 (KCNA6 or Kv1.6) is a delayed rectifier-type voltage-gated potassium channel alpha subunit belonging to the shaker-related family. The channel consists of four subunits, each with six transmembrane domains, and participates in the repolarization of the membrane potential in excitable cells such as neurons and muscle cells. KCNA6 contributes to the regulation of neurotransmitter release, heart rate, insulin secretion, and many other physiological processes. Its main mechanism involves forming a selective pore that permits potassium ions to exit the cell in response to membrane depolarization, thus restoring resting membrane potential. Recent studies have implicated de novo mutations in KCNA6 in neurodevelopmental disorders, including early-onset epilepsy and intellectual disability, due to dominant effects on channel deactivation. While there are no known highly selective drugs for Kv1.6, the target is considered significant for modulating excitability in the nervous and possibly endocrine systems.
For general potassium channel blockers: blockade of voltage-gated potassium channel pore, leading to prolonged action potentials. For activators: enhanced potassium efflux, increased membrane repolarization. For mutations: dominant-negative effects on deactivation kinetics, altered neuronal excitability.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily A member 6 (KCNA6).